Research!America President and CEO Mary Woolley Hails Senate Passage of FDA User Fee Legislation
June 26, 2012
Senate approval of the FDA Safety and Innovation Act demonstrates the willingness of lawmakers to prioritize the health and safety of patients. The bipartisanship displayed in crafting and moving the bill through Congress underscores the strong support for bringing lifesaving treatments to patients in a safe, efficient and speedy manner. The additional funding for review of prescription drugs and medical devices, along with key policy changes, will accelerate the approval process and address issues that have for too long disrupted the flow of innovative new therapies into the health care system. We urge the President to quickly sign the bill into law.
# # #